• 1
    Takayama T,Ohi M,Hayashi T,Miyanishi K,Nobuoka A,Nakajima T,Satoh T,Takimoto R,Kato J,Sakamaki S,Niitsu Y. Analysis of K-ras. APC, and β-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 2001; 121: 599611.
  • 2
    Slattery ML,Anderson K,Curtin K,Ma K,Schaffer D,Edwards S,Samowitz W. Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res 2001; 483: 7381.
  • 3
    Shivapurkar N,Huang L,Ruggeri B,Swalsky PA,Bakker A,Finkelstein S,Frost A,Silverberg S. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett 1997; 115: 3946.
  • 4
    Yuan P,Sun MH,Zhang JS,Zhu XZ,Shi DR. APC and K-ras gene mutation in aberrant crypt foci of human colon. World J Gastroenterol 2001; 7: 3526.
  • 5
    Yamashita N,Minamoto T,Ochiai A,Onda M,Esumi H. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer 1995; 75: 152733.
  • 6
    Menigatti M,Pedroni M,Verrone AM,Borghi F,Scarselli A,Benatti P,Losi L,Di Gregorio C,Schar P,Marra G,Ponz de Leon M,Roncucci L. O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis. Oncol Rep 2007; 17: 142117.
  • 7
    Johnson L,Mercer K,Greenbaum D,Bronson RT,Crowley D,Tuveson DA,Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001; 410: 111116.
  • 8
    Tuveson DA,Shaw AT,Willis NA,Silver DP,Jackson EL,Chang S,Mercer KL,Grochow R,Hock H,Crowley D,Hingorani SR,Zaks T, et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 2004; 5: 37587.
  • 9
    Jackson EL,Willis N,Mercer K,Bronson RT,Crowley D,Montoya R,Jacks T,Tuveson DA. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001; 15: 32438.
  • 10
    Alrawi SJ,Schiff M,Carroll RE,Dayton M,Gibbs JF,Kulavlat M,Tan D,Berman K,Stoler DL,Anderson GR. Aberrant crypt foci. Anticancer Res 2006; 26: 10719.
  • 11
    Madison BB,Dunbar L,Qiao XT,Braunstein K,Braunstein E,Gumucio DL. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J Biol Chem 2002; 277: 3327583.
  • 12
    Gokmen-Polar Y,Murray NR,Velasco MA,Gatalica Z,Fields AP. Elevated protein kinase C βII is an early promotive event in colon carcinogenesis. Cancer Res 2001; 61: 137581.
  • 13
    McLellan EA,Medline A,Bird RP. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis 1991; 12: 20938.
  • 14
    Murray NR,Davidson LA,Chapkin RS,Clay Gustafson W,Schattenberg DG,Fields AP. Overexpression of protein kinase C βII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J Cell Biol 1999; 145: 699711.
  • 15
    Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987; 37: 14751.
  • 16
    Chang WC,Chapkin RS,Lupton JR. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 1997; 18: 72130.
  • 17
    Murray NR,Weems C,Chen L,Leon J,Yu W,Davidson LA,Jamieson L,Chapkin RS,Thompson EA,Fields AP. Protein kinase C βII and TGFβRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis. J Cell Biol 2002; 157: 91520.
  • 18
    Kerr JF,Gobe GC,Winterford CM,Harmon BV. Anatomical methods in cell death. Methods Cell Biol 1995; 46: 127.
  • 19
    Liu Y,Su W,Thompson EA,Leitges M,Murray NR,Fields AP. Protein kinase CβII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo. J Biol Chem 2004; 279: 4555663.
  • 20
    Zhang J,Anastasiadis PZ,Liu Y,Aubrey Thompson E,Fields AP. Protein kinase CβII induces cell invasion through a RAS/MEK-, PKC/RAC 1-dependent signaling pathway. J Biol Chem 2004; 279: 2211823.
  • 21
    Di Gregorio C,Losi L,Fante R,Modica S,Ghidoni M,Pedroni M,Tamassia MG,Gafa L,Ponz de Leon M,Roncucci L. Histology of aberrant crypt foci in the human colon. Histopathology 1997; 30: 32834.
  • 22
    McLellan EA,Bird RP. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 1988; 48: 618792.
  • 23
    Cox AD,Der CJ. The dark side of Ras: regulation of apoptosis. Oncogene 2003; 22: 89999006.
  • 24
    Giehl K. Oncogenic Ras in tumour progression and metastasis. Biol Chem 2005; 386: 193205.
  • 25
    Ostrowski J,Trzeciak L,Kolodziejski J,Bomsztyk K. Increased constitutive activity of mitogen-activated protein kinase and renaturable 85 kDa kinase in human-colorectal cancer. Br J Cancer 1998; 78: 13016.
  • 26
    Licato LL,Keku TO,Wurzelmann JI,Murray SC,Woosley JT,Sandler RS,Brenner DA. In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia. Gastroenterology 1997; 113: 158998.
  • 27
    Su W,Bush CR,Necela BM,Calcagno SR,Murray NR,Fields AP,Thompson EA. Differential expression, distribution, and function of PPAR-γ in the proximal and distal colon. Physiol Genomics 2007; 30: 34253.
  • 28
    Takayama T,Katsuki S,Takahashi Y,Ohi M,Nojiri S,Sakamaki S,Kato J,Kogawa K,Miyake H,Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998; 339: 127784.
  • 29
    Nambiar PR,Nakanishi M,Gupta R,Cheung E,Firouzi A,Ma XJ,Flynn C,Dong M,Guda K,Levine J,Raja R,Achenie L, et al. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer. Cancer Res 2004; 64: 6394401.
  • 30
    Papanikolaou A,Wang QS,Papanikolaou D,Whiteley HE,Rosenberg DW. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis 2000; 21: 156772.
  • 31
    Samowitz WS,Curtin K,Schaffer D,Robertson M,Leppert M,Slattery ML. Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol Biomarkers Prev 2000; 9: 11937.
  • 32
    Elnatan J,Goh HS,Smith DR. c-Ki-ras activation and the biological behaviour of proximal and distal colonic adenocarcinomas. Eur J Cancer 1996; 32A: 4917.
  • 33
    Andreyev HJ,Norman AR,Cunningham D,Oates JR,Clarke PA. Kirsten ras mutations in patients with colorectal cancer: the multicenter “RASCAL” study. J Natl Cancer Inst 1998; 90: 67584.
  • 34
    Bleeker WA,Hayes VM,Karrenbeld A,Hofstra RM,Hermans J,Buys CC,Plukker JT. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer. Am J Gastroenterol 2000; 95: 29537.
    Direct Link:
  • 35
    Glebov OK,Rodriguez LM,Nakahara K,Jenkins J,Cliatt J,Humbyrd CJ,DeNobile J,Soballe P,Simon R,Wright G,Lynch P,Patterson S, et al. Distinguishing right from left colon by the pattern of geneexpression. Cancer Epidemiol Biomarkers Prev 2003; 12: 75562.
  • 36
    Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002; 101: 4038.
  • 37
    Milovic V,Teller IC,Faust D,Caspary WF,Stein J. Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation. Eur J Clin Invest 2002; 32: 2934.